Evidence map›Paper›PMID 36635888›Full record

ArticleThe clinical respiratory journal2023

Effect of compliance to continuous positive airway pressure on exacerbations, lung function and symptoms in patients with chronic obstructive pulmonary disease and obstructive sleep apnea (overlap syndrome).

Athanasios Voulgaris, Kostas Archontogeorgis, Stavros Anevlavis, Michail Fanaridis, Marios E Froudarakis, Sofia Schiza, Paschalis Steiropoulos

Open access · goldAbstract read
In one paragraph

Article in The clinical respiratory journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Athanasios VoulgarisDepartment of Pneumonology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.ORCID https://orcid.org/0000-0003-3486-8855
Kostas ArchontogeorgisMSc Program in Sleep Medicine, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.
Stavros AnevlavisDepartment of Pneumonology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.ORCID https://orcid.org/0000-0002-7684-3050
Michail FanaridisSleep Disorders Unit, Department of Respiratory Medicine, Medical School, University of Crete, Heraklion, Greece.ORCID https://orcid.org/0000-0002-9226-4745
Marios E FroudarakisDepartment of Pneumonology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.ORCID https://orcid.org/0000-0002-8758-666X
Sofia SchizaSleep Disorders Unit, Department of Respiratory Medicine, Medical School, University of Crete, Heraklion, Greece.
Paschalis SteiropoulosDepartment of Pneumonology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.
Democritus University of Thrace · GRUniversity of Crete · GR

Funding

Foundation of Research in Respiratory and Sleep Disorders, Alexandroupolis, Greece
6 · The paper itself

Abstract

introductionPatients with overlap syndrome (OS), that is obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD), are at increased risk of acute exacerbations related to COPD (AECOPD). We assessed the effect of CPAP compliance on AECOPD, symptoms and pulmonary function in OS patients.

methodsConsecutive OS patients underwent assessment at baseline and at 12 months under treatment with CPAP of: AECOPD and hospitalizations, COPD Assessment Test (CAT) and modified British Medical Research Council (mMRC) questionnaires, pulmonary function testing and 6-min walking test (6MWT).

resultsIn total, 59 patients (54 males) with OS were followed for 12 months and divided post hoc according to CPAP compliance into: group A with good (≥4 h CPAP use/night, n = 29) and group B with poor (<4 h CPAP use/night, n = 30) CPAP compliance. At 12 months, group A showed improvements in FEV

conclusionsWhen compared to poorly compliant patients, OS patients with good CPAP compliance had a lower number of AECOPD and showed improved lung function and COPD related symptoms.

Indexed as

Autoimmune DiseasesConnective Tissue DiseasesPulmonary Disease, Chronic ObstructiveSleep Apnea, ObstructiveContinuous Positive Airway PressureHumansLungMalePatient Compliancechronic obstructive pulmonary diseasecompliancecontinuous positive airway pressureexacerbationsobstructive sleep apneaoverlap syndrome

Identifiers

PMID36635888
PMCPMC9978906
OpenAlexW4315797231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.